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Abstract
Objective: To highlight the salient features of metastatic malignancies involving the penis, with
special reference to the primary tumour sites, metastatic mechanisms, clinical features, differential
diagnosis, treatment and prognosis.
Methods: A comprehensive search of the literature was performed using MEDLINE and EMBASE,
using the keywords 'penis', 'secondary malignancy', 'metastasis' and 'malignant priapism' to identify
reviews and case reports of secondary penile malignancy. A case of rare clinical presentation of
metastatic penile lesion is presented along with the review of the literature.
Conclusion:  Secondary malignancy of the penis is a rare clinical entity, despite the rich
vascularisation of this organ. The majority of metastatic lesions take their origin from the
neighbouring genito-urinary organs, mainly prostate and bladder. These lesions are often associated
with disseminated malignancy and hence have a poor outcome. Nodular or ulcerative lesions
involving the corpora cavernosa or priapism are the main modes of clinical presentation. In most
cases, only palliative or supportive therapy is indicated.
Background
Metastatic involvement of the penis is relatively infre-
quent, compared to its primary counterpart, despite rich
vascularisation and extensive circulatory communication
between the penis and the neighbouring organs. The vast
majority of the primary lesions are in the genitourinary
organs, with the recto sigmoid region contributing to the
bulk of the remainder [1]. Penile involvement is usually
associated with disseminated disease and generally por-
tends a poor prognosis [2]. We report an unusual presen-
tation of penile secondary from a rectal primary and a
brief review of literature.
Case report
A 73 year old man was referred with complaints of a pain-
less lesion under the foreskin and penile discharge. Five
years prior, he had undergone abdomino-perineal resec-
tion for Duke stage-B adenocarcinoma of the rectum (Fig
1). Six months later, he developed recurrence in para-aor-
tic lymph nodes and liver and was started on combination
chemotherapy. In spite of continuing chemotherapy, he
developed further recurrence locally as well as in the lung
and lower rectus muscle. At presentation, retraction of the
foreskin revealed a 1.5 cm non-tender ulcero-proliferative
lesion on his foreskin. There was a second 0.5 cm nodular
lesion on the prepuce, separate from the first. Both the
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lesions were confined to the foreskin, without any
involvement of the glans or the corpora. There was no
oedema of the prepuce or the skin of the penile shaft and
no other palpable lesions on the corpora or glans. The
superficial inguinal lymph nodes were not significantly
enlarged. Excision biopsy by circumcision revealed metas-
tasis from adenocarcinoma of rectum (Fig 2). The patient
was not offered further specific therapy because of the
advanced and progressive nature of his disease and even-
tually succumbed to it in four months time.
Discussion
Even though penile metastatic lesions are generally infre-
quent, it should always be considered in the differential
diagnosis in any patient presenting with a penile lesion or
priapism, in the setting of a disseminated malignancy.
Penile secondary lesions commonly affect the shaft or
glans penis and preputial lesions when present usually
accompany the former. Isolated secondary deposits
involving the foreskin alone, like the case presented
above, are extremely rare. To our knowledge, there is only
one previous report in the literature, of isolated metastatic
lesion on the prepuce [3].
Most penile metastases are associated with disseminated
malignancy and thereby portend a poor prognosis [4].
About 75% of the metastasis to the penis originates from
primary malignant tumours in the neighbouring urogeni-
tal organs [1,2]. Recto sigmoid cancers constitute around
13% of them [1].
History
The earliest report of secondary penile malignancy is cred-
ited to Eberth in 1870, when he reported metastasis from
an adenocarcinoma of the rectum [5]. Two years later,
Roberts noted the first case of penile secondary from a
h & e section; infiltrating rectal adenocarcinoma, reduced from ×50 Figure 1
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genitourinary primary [6]. Subsequently there were many
reports of metastasis to the penis from a wide range of pri-
mary sites, totalling to over 370 reported cases to date. In
1956, Paquin and Roland reported nine new cases and
postulated the various possible mechanisms of spread of
tumour to the penis [7]. Abeshouse et al presented a com-
prehensive review on the subject in 1961, when they sum-
marized all the 140 cases until date [2]. Further
informative reviews were written by Hayes and Young [8]
and Weitzner [9], identifying 165 cases until 1971. More
recently, Osther et al (1991) published a detailed review
on this topic revisiting the metastatic mechanisms [4].
Perez et al (1991) reviewed the literature and tabulated all
the 307 cases reported thus far, based on the primary site
of involvement [1]. Since then, another 65 cases have
been reported, excluding our current case (Table 1).
Primary tumours
The vast majority of secondary tumours in the penis take
their origin from the genitourinary organs within the pel-
vis. Previously bladder has been reported as the common-
est primary site [1,2], but a review of the literature since
1990 revealed a larger number of reported cases from pro-
static primary, making it the commonest now. The other
common primary tumours include the kidney, testis,
recto-sigmoid, rectum and colon. There are isolated
reports of metastasis to the penis from upper gastrointes-
tinal tract, lung, skin and osseous primaries. A break up of
all the primary sites is presented in Table 1.
Metastatic mechanisms
The rarity of metastatic involvement of the penis has been
a clinical enigma because of its rich vascularity and being
h & e section; metastatic adenocarcinoma deposit with surface ulceration and adjacent squamous epithelium, reduced from  ×25 Figure 2
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an end organ with respect to arterial, venous and lym-
phatic systems. Paquin and Roland in 1956 first described
the possible mechanisms by which tumour spreads to the
penis [7]. It is very difficult to elucidate the exact mode of
spread in individual cases, as penile secondaries are usu-
ally associated with disseminated disease. The five most
accepted mechanisms of spread are listed below.
a. Retrograde venous route
This is presumed to be the commonest mode of spread to
the penis [2,7]. The established communications between
the dorsal venous system of the penis and the venous
plexuses draining the pelvic viscera provide routes for easy
transportation of malignant cells. This route of spread can
explain the majority of secondary tumours arising from
the prostate, bladder and the recto-sigmoid. This would
also account for the localisation of the vast majority sec-
ondary lesions on the corpus cavernosa and the glans of
the penis. Reversal of flow in these venous channels facil-
itates direct access to the penis, for the pelvic venous
blood. Permanent reversal of flow through the communi-
cating venous channels can occur when there is blockage
more proximally, either by tumour cells within them or by
extrinsic pressure. Alternatively, there can be intermittent
episodes of retrograde flow, during phases of raised intra-
abdominal pressure, like coughing or sneezing [2].
b. Retrograde lymphatic route
The mechanism for this spread occurs in a manner similar
to the retrograde venous route [7]. The lymphatics from
the penis, as well as those from the bladder base and the
posterior surface of the prostate, drain into the external
iliac nodes. Similarly, lymphatics from the lower rectum
pass through the perineal region into the inguinal nodes
and then to the iliac nodes. These connections provide an
excellent route for the tumour spread along these vessels,
either by permeation or as emboli. This is probably the
route of spread occurring primarily to the penile skin,
rather than the corpora or the glans penis.
c. Arterial spread
This mode of spread of tumours to the penis is uncom-
mon, perhaps explaining the rarity of sarcomatous sec-
ondaries in the penis [2]. There are three possible ways in
which tumour cells can gain access to the arterial circula-
tion. These include direct tumour extension into the arte-
rial pathways (eg. branches of hypogastric artery),
secondary tumour emboli (originating from secondary
deposits in the lung) and tertiary embolism (emboli from
a metastatic liver lesion producing lung lesions, from
which emboli reach the penis) [7].
d. Direct extension
This mode of spread is possible from some highly invasive
primary tumours of the prostate and the bladder, which
enjoy close anatomical relationship with the penis [7]. In
addition, tumour cells from an aggressive low-lying rectal
carcinoma can spread along the ischi-rectal fossa, onto the
base of the penis. However, this could only account for
lesions involving the more proximal parts of the penile
shaft, which interestingly is much less common than dis-
crete lesions of the distal corpora and glans.
e. Implantation and secondary to instrumentation
These have been described as possible mechanisms for
tumour spread to the penis even though they appear
highly unlikely considering the fact that isolated lesions of
the corpus spongiosum, without concurrent involvement
of the corpora cavernosa or the glans, are practically non-
existent [7].
Table 1: Site specific list of all reported cases of secondaries to penis (total 372; 65 new cases added on to 307 reported until 2000 by 
perez et al 1)
Primary site New cases since 2000 Total number (per cent)
Prostate 32 125 (34)
Bladder 15 112 (30)
Recto-sigmoid + Rectum 8 (Rectum 7, Recto-sigmoid 1) 48 (13)
Kidney 1 30 (8)
Lower GI tract (excl. Rectum & ecto-sigmoid) 4 15 (4)
Testis 1 11 (3)
Lung 1 4 (3)
Upper airway - 4 (1)
Upper GI tract 1(Stomach) 3 (0.8)
Bone - 3 (0.8)
Ureter - 2 (0.5)
Hepato-biliary - 2 (0.5)
Others 1(Urethra) 6 (2)
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Clinical presentation
Patients with penile secondaries generally have wide-
spread metastatic disease and thereby poor general health.
However there are reports of delayed metastatic involve-
ment of the penis, years after the primary has been treated,
and without evidence of any other metastatic lesions [10].
The mean age of presentation in most tumours is between
60 and 80 yrs [4]. Even though there is no characteristic
symptom complex for secondary tumours of the penis,
most patients present with mass or induration of the
penis. Priapism is reported with varying frequencies but is
a prominent feature in nearly 40% of patients [2]. It could
be caused either by occlusion of the draining veins or sec-
ondary to thrombosis in the cavernosal spaces caused by
the infiltrating tumour cells [2]. Pain is not a prominent
symptom in most patients and when present is localised
partly to the penis and partly to the perineum [4].
Obstructive voiding symptoms and hematuria are very
rarely reported [2].
In up to 60%, the metastatic lesions present as multiple
infiltrative nodules [4]. Less commonly, they can be soli-
tary nodules or ulcerative lesions, the latter mostly in the
glans. Bilateral involvement of corpora cavernosa is seen
in up to 65% of cases and 15% has unilateral corporal
lesions. Lesions of the glans penis may be seen in 10%,
though many have synchronous involvement of the cor-
pora as well. Preputial lesions are uncommon and are
usually associated with involvement of the corpora or
glans [2].
Diagnosis and treatment
Diagnosis is usually made by biopsy or corporeal aspira-
tion, which help to differentiate between metastasis and
primary tumours. Cavernosography, though useful to
delineate the extent of involvement of the corporal bod-
ies, is disadvantaged by the fact that it is invasive [11].
Metastatic lesions usually present as filling defects or
structural deformities of the corporal bodies or glans. In
the presence of malignant priapism, obstruction of penile
venous flow can also be demonstrated. Non-invasive
modalities like colour-coded duplex ultrasonography, CT
scan and MRI are being increasingly used to stage the dis-
ease. Ultrasonography is operator dependant whereas
imaging in only one plane limits the diagnostic value of
CT. MR scanning is a reliable alternative for confirming
the diagnosis and assessing the extend of the disease. On
T1-weighted images, these lesions have low signal inten-
sity, isointense with the surrounding corpus cavernosum.
On T2-weighted imaging, they appear inhomogenous
with low to intermediate signal intensity, seen clearly
against the high background intensity of the cavernosal
bodies [12].
The main differential diagnosis include primary benign
and malignant penile lesions, chancre, chancroid, non-
tumourous priapism, peyronie's disease, tuberculosis and
non-specific inflammatory and suppurative lesions of the
penis [2]. (Table 2)
The choice of treatment is greatly influenced by the gen-
eral health of the patient, as well as the site of primary,
extent of metastatic spread and the severity of symptoms.
Most patients will require only supportive or palliative
therapy. Local excision, partial or complete penectomy,
external beam radiotherapy and chemotherapy have all
yielded uniformly poor results. Hormonal manipulation
has been tried for secondaries from prostatic adenocarci-
noma, though without much success [2]. Brachytherapy
can be used to deliver high local doses of radiation and
Table 2: Differential diagnosis of metastatic penile lesions
Pre-malignant and malignant lesions
• Bowen's disease/Erythroplacia of Querat
• Verrucous carcinoma
• Squamous cell carcinoma
• Basal cell carcinoma
• Melanoma
• Sarcoma
Infectious lesions
• Tuberculosis
• Syphilitic chancre
• Chancroid
• Cryptococal infection
• Filariasis
• Rhinosporiodiosis
Other benign conditions
• Non-tumourous priapism
• Peyronnie's disease
• Factitous ulcerations (self induced)
• Pseudo tumours (secondary to foreign bodies or injections into penis)Publish with BioMed Central    and   every 
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has been shown to control local disease progression for
up to one year [13].
Prognosis
In general, the outlook for patients presenting with sec-
ondary malignancy in the penis is very poor, irrespective
of the site of primary and the type of therapy. Most
patients have widespread metastatic disease and are in a
state of poor general health. Except for a few patients with
small isolated lesions, which might respond to wide exci-
sion or penectomy, the majority succumb to the disease
process within a year of presentation [14]. For intractable
pain, total penectomy or dorsal nerve section may be indi-
cated [15,16]. Overall patients with rectal primaries seems
to fare slightly better, with two patients surviving over
nine years [2]. Patients with genitourinary primary had an
average survival of 47 weeks only, even with some form of
treatment [14]. The longest recorded survival in this group
is 7 years, for a patient with prostatic adenocarcinoma
[17].
Conclusion
Secondary malignancy of the penis is an uncommon clin-
ical entity. However the rarity of these lesions and the var-
ied modes of clinical presentation necessitate a good
working knowledge of this condition to plan appropriate
treatment in these patients. The majority arise from pros-
tate, bladder or the recto-sigmoid and is usually associ-
ated with disseminated metastatic disease. The common
mode of spread to the penis is by retrograde venous route.
However, in the presented case, retrograde lymphatic
spread may be a more plausible explanation for the
metastasis occurring only to the penile foreskin, without
involvement of the corpora or glans. The overall outcome
is very poor and most patients will need only palliative or
supportive care.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Acknowledgements
To Dr Faisal Ali, Consultant Pathologist, Bradford Royal Infirmary for the 
microphotographs.
References
1. Perez LM, Shumway RA, Carson CC, Fisher SR, Hudson WR: Penile
metastasis secondary to supraglottic squamous cell carci-
noma: Review of the literature.  J Urol 1992, 147:157.
2. Abeshouse BS, Abeshouse GA: Metastatic tumours of the penis:
A review of the literature and a report of two cases.  J Urol
1961, 86:99.
3. Tan HT, Vishniavsky S: Carcinoma of the prostate with metas-
tases to the prepuce.  J Urol 1971, 106:588.
4. Osther PJ, Lontoff E: Metastasis to the penis: Case reports and
review of literature.  Int Urol Nephr 1991, 23(2):161.
5. Eberth CJ: Krehsmetastasen des corpus cavernosum penis.
Virch Arch 1870, 51:145.
6. Roberts W: A practical treatise on urinary and renal disease.
2nd edition. London: Smith, Elder & Co; 1872:517. 
7. Paquin AJ Jr, Roland SI: Secondary carcinoma of the penis, A
review of the literature and a report of nine new cases.  Can-
cer 1956, 9(3):626.
8. Hayes WT, Young JM: Metastatic carcinoma of the penis.  J
Chron Dis 1967, 20:891.
9. Weitzner S: Secondary carcinoma in the penis: report of three
cases and literature review.  Amer Surg 1971, 37:563.
10. Berger AP, Rogatsch H, Hoeltl L, Steiner H, Bartsch G, Hobisch A:
Late penile metastasis from primary bladder carcinoma.
Urology 2003, 62(1):145.
11. Escribano G, Allona A, Burgos FJ, Garcia R, Navio S, Escudero A:
Cavernosography in diagnosis of metastatic tumours of
penis: 5 new cases and a review of the literature.  J Urol 1987,
138:1174.
12. Lau TN, Wakeley CJ, Goddard P: Magnetic Resonance imaging of
penile metastais; A report on five cases.  Australasian Radiology
1999, 43:378-81.
13. Griffin JH, Wheeler JS, Olson M, Melian E: Prostatic carcinoma
metastatic to the penis: Magnetic resonance imaging and
brachytherapy.  J Urol 1996, 156:1701.
14. Robey EL, Schellhammer PF: Four cases of metastases to the
penis and a review of the literature.  J Urol 1984, 132:992.
15. Mukamel E, Farrer J, Smith RB, deKernion JB: Metastatic carci-
noma for penis: when is total penectomy indicated?  Urology
1987, 29:15-18.
16. Hill JT, Khalid MA: Penile denervation.  Br J Urol 1988, 61:167.
17. Whitmore WF Jr: The rationale and results of ablative surgery
for prostatic cancer.  Cancer 1963, 16:1119.